Neurostimulation in a neural fulcrum zone for the treatment of chronic cardiac dysfunction
Systems and methods are provided for delivering neurostimulation therapies to patients for treating chronic heart failure. A neural fulcrum zone is identified and ongoing neurostimulation therapy is delivered within the neural fulcrum zone. This neural fulcrum zone corresponds to a combination of stimulation parameters at which autonomic engagement is achieved, while the tachycardia-inducing stimulation effects are offset by the bradycardia-inducing effects, thereby minimizing side effects such as significant heart rate changes while providing a therapeutic level of stimulation.
1. A method of operating an implantable medical device (IMD) comprising a neurostimulator coupled to an electrode assembly, the neurostimulator adapted to deliver a stimulation signal to a patient, the method comprising:
activating the IMD to generate a plurality of stimulation signals, each stimulation signal of the plurality of stimulation signals having at least one parameter setting that is different as compared to a corresponding parameter setting of the other stimulation signals of the plurality of stimulation signals;
detecting a heart rate condition of the patient during the generation of the plurality of stimulation signals by:
detecting a tachycardia condition in response to detecting a heart rate increase responsive to a first subset of the stimulation signals;
detecting a bradycardia condition in response to detecting a heart rate reduction of greater than a predefined threshold responsive to a second subset of the stimulation signals; and
detecting a transition heart rate response corresponding to a neural fulcrum zone in response to detecting a heart rate reduction between a baseline heart rate and a predefined threshold responsive to a third subset of the stimulation signals, the transition heart rate response being between a heart rate associated with the tachycardia condition and a heart rate associated with the bradycardia condition.
2. A method according to claim 1 , further comprising:
activating the IMD to chronically deliver the third subset of stimulation signals corresponding to the identified neural fulcrum zone.
3. A method according to claim 2 , wherein the activating the IMD to chronically deliver the third subset of stimulation signals comprises activating the IMD to treat a chronic cardiac dysfunction condition of the patient.
4. A method according to claim 1 , wherein the at least one parameter setting comprises an amplitude setting.
5. A method according to claim 1 , wherein the at least one parameter setting comprises a pulse width setting.
6. A method according to claim 1 , wherein the at least one parameter setting comprises a duty cycle setting.
7. A method according to claim 1 , wherein the at least one parameter setting comprises a frequency setting.
8. A method according to claim 1 , wherein the plurality of stimulation signals includes a series of stimulation signals having a greater amplitude as compared to an immediately previous stimulation signal.
9. A method according to claim 1 , wherein the plurality of stimulation signals is a first plurality of stimulating signals having a first frequency, the method further comprising:
activating the IMD to generate a second plurality of stimulation signals having a second frequency different than the first frequency, each stimulation signal of the second plurality of stimulation signals having at least one parameter setting that is different as compared to a corresponding parameter setting of the other stimulation signals of the second plurality of stimulation signals;
detecting the heart rate condition of the patient during the generation of the second plurality of stimulation signals by:
detecting another tachycardia condition in response to detecting a heart rate increase response to a first subset of the second stimulation signals;
detecting another bradycardia condition in response to detecting a heart rate reduction of greater than the predefined threshold responsive to a second subset of the second stimulation signals; and
detecting another transition heart rate corresponding to a neural fulcrum zone in response to detecting a heart rate reduction between a baseline heart rate and a predefined threshold responsive to a third subset of the second stimulation signals, the another transition response being a heart rate associated with the another tachycardia condition and a heart rate associated with the another bradycardia condition.
10. A method according to claim 9 , further comprising:
activating the IMD to chronically deliver the third subset of stimulation signals corresponding to the another neural fulcrum zone.
11. A method according to claim 10 , wherein the activating of the IMD to chronically deliver the third subset of stimulation signals comprises activating the IMD to treat a chronic cardiac dysfunction condition of the patient.
12. A method according to claim 1 , further comprising:
prior to activating the IMD to generate the plurality of stimulation signals, completing a titration process in which a stimulation intensity is gradually increased over a period of time.
13. A method according to claim 1 , wherein the IMD is adapted to deliver the stimulation signal to a vagus nerve of the patient.
14. A method of identifying a set of parameter settings for an implantable medical device (IMD) for treating a chronic cardiac dysfunction condition of a patient, the method comprising:
activating the IMD to generate a plurality of stimulation signals at a same frequency, each stimulation signal of the plurality of stimulation signals having at least one parameter setting that is different as compared to a corresponding parameter setting of the other stimulation signals of the plurality of stimulation signals;
detecting a heart rate condition of the patient during the generation of the plurality of stimulation signals by;
detecting a tachycardia condition in response to detecting a heart rate increase responsive to a first subset of the stimulation signals; and
detecting a bradycardia condition in response to a heart rate reduction of greater than a predefined threshold responsive to a second subset of the stimulation signals;
detecting a transition heart rate response corresponding to a neural fulcrum zone in response to detecting a heart rate reduction between a baseline heart rate and a predefined threshold responsive to a third subset of the stimulation signals, the transition heart rate response comprising a heart rate reduction between a baseline heart rate and the predefined threshold; and
identifying the set of parameter settings for treating the chronic cardiac dysfunction condition as the parameters of the third subset of the stimulation signals.
15. A neurostimulation system, comprising:
an electrode assembly; and
a neurostimulator coupled to the electrode assembly, the neurostimulator comprising:
a control circuit; and
a memory operably coupled to the control circuit and comprising instructions that, when executed by the control circuit, cause the control circuit to:
detect a heart rate condition when the IMD generates the plurality of stimulation signals, each stimulation signal of the plurality of stimulation signals having at least one parameter setting that is different as compared to a corresponding parameter setting of the other stimulation signals of the plurality of stimulation signals;
detect a tachycardia condition in response to detecting a heart rate increase responsive to a first subset of the stimulation signals;
detect a bradycardia condition in response to detecting a heart rate reduction of greater than a predefined threshold responsive to a second subset of the stimulation signals; and
detect a transition heart rate response corresponding to a neural fulcrum zone in response to detecting a heart rate reduction between a baseline heart rate and a predefined threshold responsive to a third subset of the stimulation signals, the transition heart rate response being between a heart rate associated with the tachycardia condition and a heart rate associated with the bradycardia condition.
16. A system according to claim 15 , wherein the control system is further programmed to:
activate the neurostimulator to chronically deliver the third subset of stimulation signals corresponding to the neural fulcrum zone.
17. A system according to claim 16 , wherein the control system is programmed to activate the neurostimulator to chronically deliver the third subset of stimulation signals to treat a chronic a cardiac dysfunction condition of the patient.
18. A system according to claim 15 , wherein the at least one parameter setting comprises at least one of an amplitude setting, a pulse width setting, a duty cycle setting, or a frequency setting.
19. A system according to claim 15 , wherein the plurality of stimulation signals includes a series of stimulation signals having a greater amplitude as compared to an immediately previous stimulation signal.
20. A system according to claim 15 , wherein the plurality of stimulation signals is a first plurality of stimulation signals having a first frequency and wherein the control system is further programmed to:
activate the neurostimulator to generate a second plurality of stimulation signals having a second frequency different than the first frequency, each stimulation signal of the second plurality of stimulation signals having at least one parameter setting that is different as compared to a corresponding parameter setting of the other stimulation signals of the second plurality of stimulation signals;
detecting the heart rate condition of the patient during the generation of the second plurality of stimulation signals by:
detecting another tachycardia condition in response to detecting a heart rate increase response to a first subset of the second stimulation signals;
detecting another bradycardia condition in response to detecting a heart rate reduction of greater than the predefined threshold responsive to a second subset of the second stimulation signals; and
detecting another transition heart rate corresponding to a neural fulcrum zone in response to detecting a heart rate reduction between a baseline heart rate and a predefined threshold responsive to a third subset of the second stimulation signals, the another transition response being a heart rate associated with the another tachycardia condition and a heart rate associated with the another bradycardia condition.